Discounted Cash Flow
Charles River Laboratories International, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $1.7b | $154.8m | $245.1m | 9.2% | $3.29 |
| 2017 | $1.9b (10.5%) | $123.4m (-20.3%) | $271.9m (10.9%) | 6.6% (-27.9%) | $2.60 (-21.0%) |
| 2018 | $2.3b (22.0%) | $226.4m (83.5%) | $416.0m (53.0%) | 10.0% (50.4%) | $4.72 (81.5%) |
| 2019 | $2.6b (15.7%) | $252.0m (11.3%) | $458.6m (10.2%) | 9.6% (-3.8%) | $5.17 (9.5%) |
| 2020 | $2.9b (11.5%) | $364.3m (44.6%) | $519.9m (13.4%) | 12.5% (29.6%) | $7.35 (42.2%) |
| 2021 | $3.5b (21.1%) | $391.0m (7.3%) | $715.2m (37.6%) | 11.0% (-11.4%) | $7.77 (5.7%) |
| 2022 | $4.0b (12.3%) | $486.2m (24.4%) | $461.4m (-35.5%) | 12.2% (10.7%) | $9.57 (23.2%) |
| 2023 | $4.1b (3.9%) | $474.6m (-2.4%) | $629.7m (36.5%) | 11.5% (-6.0%) | $9.27 (-3.1%) |
| 2024 | $4.0b (-1.9%) | $22.2m (-95.3%) | $681.7m (8.3%) | 0.5% (-95.2%) | $0.20 (-97.8%) |
| 2025 | $4.0b (-0.9%) | $-144.3m (-750.1%) | $717.6m (5.3%) | -3.6% (-755.7%) | $-2.91 (-1555.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.